Skip to main content

Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer

CBE ID
0219
Project
Endorsed
New or Maintenance
Endorsement and Maintenance (E&M) Cycle
Is Under Review
No
Measure Description

Percentage of female patients, age = 18 and < 70 at diagnosis, who have their first diagnosis of cancer (epithelial malignancy), whose primary tumor is of the breast, had breast conserving surgery and was administered radiation therapy within 1 year (365 days) of diagnosis

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    Care Setting
    Numerator

    Radiation therapy is administered within 1 year (365 days) of the date of diagnosis

    Denominator

    Include if all of the following characteristics are identified:
    Women
    Age = 18 and < 70 at time of diagnosis
    Known or assumed to be first or only cancer diagnosis
    Epithelial malignancy only
    Invasive tumors
    Primary tumors of the breast
    All or part of 1st course of treatment performed at the reporting facility
    Known to be alive within 1 year (365 days) of date of diagnosis
    Receipt of breast conserving surgery

    Exclusions

    Exclude, if any of the following characteristics are identified:
    Men
    Under age 18 or over 69 at time of diagnosis
    Second or subsequent cancer diagnosis
    Tumor not originating in the breast
    Non-epithelial malignancies, exclude rare tumors: 8940 - Mixed tumor, malignant, NOS; 8950 - Mullerian mixed tumor; 8980 - Carcinosarcoma; 8981 - Carcinosarcoma, embryonal
    Non-invasive tumor
    Stage 0, in-situ tumor
    Stage IV, metastatic tumor
    None of 1st course therapy performed at reporting facility
    Breast conserving surgery was not received
    Died within 1 year (365 days) of diagnosis
    Patient enrolled in a clinical trial that directly impacts delivery of the standard of care

    Testing Data Sources
  • Most Recent Endorsement Activity
    Endorsed Cancer Fall Cycle 2019
    Initial Endorsement
    Next Planned Maintenance Review
    Cancer Fall 2023
    Endorsement Status
    Last Updated